Chemomab Therapeutics (CMMB) Q1 2024 Earnings

9MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q1 2024
-0.72
-0.49
-0.25
-0.02

Details

Expected EPS
N/A
Actual EPS
-0.28
Surprise EPS
-0.28
Surprise Percent
+∞%

Description

Chemomab Therapeutics (CMMB) has reported earnings of -0.28 per share for Q1 2024.

0 Comments

Share your thoughts